These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 3885896

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
    Stöckbauer P, Malasková V, Soucek J, Chudomel V.
    Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
    [Abstract] [Full Text] [Related]

  • 43. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
    Kikuchi K, Koshiba H, Kasai K, Hiratsuka H, Fujimoto N, Uede T.
    Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
    [Abstract] [Full Text] [Related]

  • 44. Characteristics of a monoclonal antibody (RM124) against acute myelocytic leukemia cells.
    Martens AC, Johnson RJ, Kaizer H, Hagenbeek A.
    Exp Hematol; 1984 Sep; 12(8):667-71. PubMed ID: 6386506
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. A monoclonal antibody defining a lymphoma-associated antigen in man.
    Nadler LM, Stashenko P, Hardy R, Schlossman SF.
    J Immunol; 1980 Aug; 125(2):570-7. PubMed ID: 6156208
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Specific xenogenous antiserum to cells of chronic myeloid leukemia (CML) in blastic crisis.
    Baryshnikov AJ, Radzikhovskaya RM, Morozova LF, Belyanchikova NI, Slavina EG, Vinogradova JE, Mkheidze DM, Polotskaya TM, Volkova MA, Svet-Moldavsky GJ, Nikitin VD, Kutimov VA, Trubitsina VI, Goletsky SA, Glazunov A.
    Biomedicine; 1976 Dec 05; 25(9):316-7. PubMed ID: 1069594
    [Abstract] [Full Text] [Related]

  • 51. A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
    Nadler LM, Ritz J, Hardy R, Pesando JM, Schlossman SF, Stashenko P.
    J Clin Invest; 1981 Jan 05; 67(1):134-40. PubMed ID: 6969730
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Use of antilymphocyte globulin as a study method in the identification of lymphoid antigens expressed by populations of leukemic and/or lymphomatous cells].
    Marmont A.
    Minerva Med; 1978 Apr 14; 69(18):1263-74. PubMed ID: 351459
    [No Abstract] [Full Text] [Related]

  • 54. Human monoclonal antibodies to human leukemias. Initial characterization of specificities and antigens.
    Posner MR, Santos DJ, Elboim HS, Frackelton AR.
    Prog Clin Biol Res; 1989 Apr 14; 288():95-9. PubMed ID: 2717644
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Diagnostic specificity of the monoclonal anti-CALLA antibody VIL-A1 in leukemia and malignant lymphoma.
    Knapp W, Lutz D, Bettelheim P, Radaszkiewicz T, Majdic O, Gadner H.
    Med Oncol Tumor Pharmacother; 1984 Apr 14; 1(1):25-32. PubMed ID: 6242421
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.